Solara Active

SOLARAACTIVEPHARMASCIENCES03 May 2024

Pharmaceuticals

₹

+20.40 (+3.83%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Solara Active

Solara Active

Pharmaceuticals

SOLARAACTIVEPHARMASCIENCES03 May 2024

₹

+20.40 (+3.83%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
06-May-2021	D	Results - Financial Results for March 31, 2021. Recommended dividend of Rs. 3/-per equity share (30%) for the year ended March 31, 2021, subject to the approval of shareholders of the company at the ensuing Annual General Meeting. The dividend will be paid within 30 days from the date of ensuing Annual General Meeting of the Company. Solara Active Pharma Sciences Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 21, 2021 to August 25, 2021 (both days inclusive) for the purpose of Payment of Dividend & 4th Annual General Meeting (AGM) of the Company to be held on August 25, 2021. (As Per BSE Announcement dated on 29.07.2021)	18-Aug-2021
11-Nov-2020	D	Declared Interim Dividend of Rs 4.00/- (Rupees Four only) per share i.e. @ 40% per fully paid up equity share of Rs 10/- each for the financial year 2020-21. The record date for the purpose of payment of dividend is Friday, November 20, 2020. The Interim Dividend shall be paid to those shareholders whose names are appearing in the register of members or in the records of the depositories as beneficial owner of the shares on the Record Date. The interim dividend will be paid within stipulated timelines as prescribed under law.	19-Nov-2020
07-May-2020	D	We wish to inform you that the Board of Directors at their meeting held today i.e. May 7, 2020 have recommended dividend of Rs. 2/-per equity share (20%) for the year ended March 31, 2020 subject to the approval of shareholders of the company at the ensuing Annual General Meeting. The dividend will be paid within 30 days from the date of ensuing Annual General Meeting of the Company.	28-Jul-2020
16-May-2019	D	We wish to inform you that the Board of Directors at their meeting held today i.e. May 16, 2019 have recommended maiden dividend of Rs. 5/- per equity share (50%) for the year ended March 31, 2019 subject to the approval of shareholders of the company at the ensuing Annual Meneral Meeting. The dividend will be paid within 30 days from the date of ensuing Annual General Meeting of the Company.	06-Aug-2019
07-Mar-2024	BC	Notice of Postal Ballot POM 08/04/2024 (As Per BSE Bulletin Dated on 11.03.2024) Scrutinizer Report and Voting Result (As Per BSE Announcement dated on 08.04.2024)	06-Apr-2024
08-Mar-2024	BC	Appointment of Chief Financial Officer	08-Mar-2024
14-Feb-2024	BC	Resignation of Mr. P V Raghavendra Rao from the position of Chief Financial Officer of the Company from the close of business hours of February 15, 2024.	15-Feb-2024
05-Feb-2024	BC	Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve unaudited financial results f	14-Feb-2024
14-Feb-2024	BC	Appointment of Mr. M Mohan as Executive Director of the Company with effect from February 14 2024.	14-Feb-2024

No Rights has been declared by SOLARAACTIVEPHARMASCIENCES

Book Closure

Record Date	Split Date	Purpose
06-Apr-2024	01 Jan'1900	Notice of Postal Ballot POM 08/04/2024 (As Per BSE Bulletin Dated on 11.03.2024) Scrutinizer Report and Voting Result (As Per BSE Announcement dated on 08.04.2024)
08-Mar-2024	-	Appointment of Chief Financial Officer
15-Feb-2024	-	Resignation of Mr. P V Raghavendra Rao from the position of Chief Financial Officer of the Company from the close of business hours of February 15, 2024.
14-Feb-2024	-	Solara Active Pharma Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve unaudited financial results f
14-Feb-2024	-	Appointment of Mr. M Mohan as Executive Director of the Company with effect from February 14 2024.

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Solara Active Pharma Sciences Ltd ₹553.60(+20.40/3.83%)	553.60	+20.40	1,992.75	46.90	0.00	1.36
Lupin Ltd ₹1,654.75(+7.10/0.43%)	1,654.75	+7.10	75,415.25	133.18	36.60	3.91
Ipca Laboratories Ltd ₹1,337.70(-13.30/-0.98%)	1,337.70	-13.30	33,938.01	88.94	61.57	5.46
J B Chemicals & Pharmaceuticals Ltd ₹1,889.90(+4.30/0.23%)	1,889.90	+4.30	29,330.27	80.31	57.90	10.92
Sanofi India Ltd ₹8,624.25(-53.50/-0.62%)	8,624.25	-53.50	19,861.65	59.17	33.61	19.54
IOL Chemicals & Pharmaceuticals Ltd ₹395.55(+3.25/0.83%)	395.55	+3.25	2,322.10	-0.40	13.44	1.46

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	248.73	425.24	352.31	380.62	394.75	338.37
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	248.73	425.24	352.31	380.62	394.75	338.37
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.44	1.23	2.07	5.12	6.77	3.77
Total Income	249.17	426.47	354.38	385.74	401.52	342.14
Total Expenditure	473.17	391.12	333.17	329.07	349.46	310.85
PBIDT	-224.00	35.35	21.21	56.67	52.06	31.29
Interest	25.37	24.47	25.51	21.96	23.64	21.96
PBDT	-249.37	10.88	-4.30	34.71	28.42	9.33
Depreciation	25.96	26.14	25.83	26.40	27.89	28.56
Tax	0.00	0.00	0.00	0.00	-0.11	0.00
Deferred Tax	0.00	0.00	-10.25	1.85	0.22	-9.32
Reported Profit After Tax	-275.33	-15.26	-19.88	6.46	0.42	-9.91
Extra-ordinary Items	-62.77	-3.55	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-212.56	-11.71	-19.88	6.46	0.42	-9.91

EPS (Unit Curr.)	-76.49	-4.24	-5.52	1.79	0.12	-2.75
EPS (Adj) (Unit Curr.)	-76.49	-4.24	-5.52	1.79	0.12	-2.75
Calculated EPS (Unit Curr.)	-76.48	-4.24	-5.52	1.79	0.12	-2.75
Calculated EPS (Adj) (Unit Curr.)	-76.48	-4.24	-5.52	1.79	0.12	-2.75
Calculated EPS (Ann.) (Unit Curr.)	-305.92	-16.96	-22.09	7.18	0.47	-11.01
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-305.92	-16.96	-22.09	7.18	0.47	-11.01
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	36.00	36.00	36.00	36.00	36.00	36.00
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-90.06	8.31	6.02	14.89	13.19	9.25
PBDTM(%)	-100.26	2.56	-1.22	9.12	7.20	2.76
PATM(%)	-110.69	-3.59	-5.64	1.70	0.11	-2.93

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	248.73	425.24	352.31	380.62	394.75	338.37
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	248.73	425.24	352.31	380.62	394.75	338.37
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.45	1.18	2.04	4.68	7.17	3.72
Total Income	249.18	426.42	354.35	385.30	401.92	342.09
Total Expenditure	473.19	392.83	333.19	331.85	349.75	310.80
PBIDT	-224.01	33.59	21.16	53.45	52.17	31.29
Interest	25.37	24.44	24.61	21.96	23.64	21.96
PBDT	-249.38	9.15	-3.45	31.49	28.53	9.33
Depreciation	25.96	26.21	25.91	26.45	27.98	28.63
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	-0.56	-0.10	0.00
Deferred Tax	0.00	0.00	-10.25	1.84	0.22	-9.32
Reported Profit After Tax	-275.34	-17.06	-19.11	3.76	0.43	-9.98
Minority Interest After NP	0.00	0.10	0.44	-0.01	-0.02	-0.02
Net Profit after Minority Interest	-275.34	-17.16	-19.55	3.77	0.45	-9.96

Extra-ordinary Items	-62.77	-5.22	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-212.57	-11.94	-19.55	3.77	0.45	-9.96

EPS (Unit Curr.)	-76.49	-4.77	-5.43	1.05	0.12	-2.77
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	36.00	36.00	36.00	36.00	36.00	36.00

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-90.06	7.90	6.01	14.04	13.22	9.25
PBDTM(%)	-100.26	2.15	-0.98	8.27	7.23	2.76
PATM(%)	-110.70	-4.01	-5.42	0.99	0.11	-2.95

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	36.00	36.00	35.93	26.85	25.77	24.67
Reserves Total	1467.13	1491.05	1556.86	967.94	832.68	745.19
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	96.00	104.00	0.00
Total Shareholders Funds	1503.13	1527.05	1592.79	1090.79	962.45	769.86
Secured Loans	1001.15	1024.57	606.91	706.79	538.05	632.87
Unsecured Loans	11.70	12.80	13.82	15.17	0.00	0.00
Total Debt	1012.85	1037.37	620.73	721.96	538.05	632.87
Total Liabilities	2515.98	2564.42	2213.52	1812.75	1500.50	1402.73
APPLICATION OF FUNDS :
Gross Block	1871.26	1764.06	1678.31	1587.46	1311.32	1099.10
Less : Accumulated Depreciation	529.25	429.91	319.30	213.37	116.58	36.56
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1342.01	1334.15	1359.01	1374.09	1194.74	1062.54
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	238.47	238.65	87.72	40.21	39.20	70.31
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	16.05	14.77	18.13	18.03	18.12	18.53
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	558.09	575.55	294.97	279.73	213.94	187.66
Sundry Debtors	539.65	489.67	483.81	229.67	290.24	263.35
Cash and Bank	8.71	47.14	198.38	56.58	76.37	46.93
Loans and Advances	84.42	127.51	80.83	109.37	69.11	110.59
Total Current Assets	1190.87	1239.87	1057.99	675.35	649.66	608.53
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	327.44	308.96	329.34	249.38	334.89	341.14
Provisions	2.08	3.44	1.83	1.86	2.36	1.27
Total Current Liabilities	329.52	312.40	331.17	251.24	337.25	342.41
Net Current Assets	861.35	927.47	726.82	424.11	312.41	266.12
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	161.85	135.99	108.24	86.08	12.45	10.45
Deferred Tax Liability	83.31	80.85	82.69	97.92	45.28	58.88
Net Deferred Tax	78.54	55.14	25.55	-11.84	-32.83	-48.43
Total Assets	2536.42	2570.18	2217.23	1844.60	1531.64	1369.07
Contingent Liabilities	3.61	3.49	6.22	4.86	6.19	7.62

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	36.00	36.00	35.93	26.85	25.77	24.67
Reserves Total	1464.21	1488.87	1552.60	963.09	826.10	739.30
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	96.00	104.00	0.00
Total Shareholders Funds	1500.21	1524.87	1588.53	1085.94	955.87	763.97
Minority Interest	2.24	2.31	4.24	4.29	4.38	4.48
Secured Loans	1001.15	1024.57	606.91	706.79	538.06	632.87
Unsecured Loans	11.70	12.80	13.82	15.17	0.00	0.00
Total Debt	1012.85	1037.37	620.73	721.96	538.06	632.87
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	49.45	60.62	65.47	76.08	86.50	23.83
Total Liabilities	2564.75	2625.17	2278.97	1888.27	1584.81	1425.15
APPLICATION OF FUNDS :
Gross Block	1895.10	1779.36	1702.15	1611.23	1334.83	1122.64
Less: Accumulated Depreciation	531.14	422.97	320.57	214.29	117.03	36.71
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	1363.96	1356.39	1381.58	1396.94	1217.80	1085.93
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	238.47	238.65	87.98	40.47	40.37	71.48
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	1.70	0.42	0.42	0.32	0.41	0.81
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	558.09	575.55	294.97	279.73	213.94	187.66
Sundry Debtors	536.99	489.67	483.87	226.53	288.80	262.52
Cash and Bank	8.89	47.25	198.54	56.78	76.47	47.01
Loans and Advances	83.57	126.81	80.25	108.95	68.89	110.63
Total Current Assets	1187.54	1239.28	1057.63	671.99	648.10	607.82
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	332.44	316.02	332.64	250.70	338.00	343.16
Provisions	2.09	3.77	1.97	2.70	4.41	4.78
Total Current Liabilities	334.53	319.79	334.61	253.40	342.41	347.94
Net Current Assets	853.01	919.49	723.02	418.59	305.69	259.88
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	161.87	135.99	108.30	86.16	54.11	21.57
Deferred Tax Liability	83.31	80.85	82.69	97.92	86.87	69.94
Net Deferred Tax	78.56	55.14	25.61	-11.76	-32.76	-48.37
Other Assets	29.05	55.08	60.36	43.71	53.30	55.43
Total Assets
Contingent Liabilities	3.61	3.22	6.22	4.86	6.19	7.62

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	46.27	197.53	55.84	75.62	45.87
Net Cash from Operating Activities	156.17	-241.77	154.44	242.02	165.72
Net Cash Used In Investing Activities	-81.13	-243.08	-105.25	-358.81	-112.97
Net Cash Used In Financing Activities	-112.76	333.59	92.50	97.01	-23.00
Net Inc./Dec In Cash And Cash Equivalents	-37.72	-151.26	141.69	-19.78	29.75
Cash And Cash Equivalents At End Of The Year	8.55	46.27	197.53	55.84	75.62

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

30.49%

FII Shareholding

15.80%

DII Shareholding

2.98%

Public Shareholding

50.74%

**Promoter pledged shareholding 30.49%

About Solara Active Pharma Sciences Ltd

Solara Active Pharma Sciences Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 1989.33 crores. It has reported a sales of Rs. 248.73 crores and a net profit of Rs. -275.33 crores for the quarter ended December 2018. The company management includes Aditya Puri, Aditya Puri,Nirmal P Bhogilal,Vineeta Rai,RAJAGOPALAN RAMAKRISHNAN,Kausalya Santhanam,ANKUR NAND THADANI,Arun Kumar,S Hariharan,Jitesh Devendra,Poorvank Purohit,Rajendra Kumar Srivastava,Rajiv Vijay Naba (Solara Active Pharma Sciences Ltd) among others.

Chairman

Aditya Puri

Registered office

201 Devavrata Sector 17 Vashi,Navi Mumbai,Mumbai,Maharashtra,400703

FAX :91-22-27892942

Background

Incorporation Year2017

Face Value₹10

Market Lot1

How to buy Solara Active shares on nse?

To buy Solara Active shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Solara Active share price today?

The Solara Active shares price on nse is Rs.553.6 today.

What is the market cap of Solara Active shares on NSE ?

The company has a market capitalization of Rs.1992.75Cr

What is the PE & PB ratio of Solara Active shares ?

PE is 0 and PB is 1.36

What is the 52 Week High and Low of Solara Active shares?

Solara Active stock price high: Rs.606.4 Solara Active stock price low: Rs.286

How do I invest in Solara Active Pharma shares?

To invest in Solara Active Pharma shares through Motilal Oswal, open a trading account, complete KYC formalities, transfer funds, log in to the trading platform, search for the shares, buy them, and wait for them to be credited to your demat account.

What will be the future of Solara Active Pharma shares?

While Solara’s stock has shed value in the past year, it has now returned to profitability. Additionally, the Founder and Non-Executive Director Arun Pillai bought shares well above current rates to infuse optimism amongst potential investors. That is an indication of confidence in upward movement of the stock.

What are the factors that influence the share price of Solara Active Pharma?

The financial performance of the company, including revenue growth, profitability, and earnings, can affect its share price. Furthermore, macroeconomic factors such as interest rates, inflation, investor perception of the Indian market, and industry trends can affect Solara’s share price.

What is the long-term growth potential of Solara Active Pharma?

Solara Active Pharma shows great potential for growth after amalgamating Aurore Life Science, Empyrean Lifesciences, and Hydra Active Pharma into Solara. Additionally, the WHO recently completed an inspection of the Cuddalore facility, which is expected to boost the share price in the long term.

What is the upcoming dividend for Solara Active Pharma shares?

Solara paid its last dividend of Rs. 3 per share on May 6th, 2021. Despite the company turning a profit in December 2022, there is no news of an upcoming dividend.

How often are dividends paid on Solara Active Pharma shares?

Solara Active Pharma has declared dividend four times in the last five years.

6th May, 2021 (Rs. 3/share)
6th November, 2020 (Rs. 4/share)
7th May, 2020 (Rs. 2/share)
16th May, 2019 (Rs. 5/share)